Modulating Inflammation for the Treatment of Disease: Novel Therapeutic Approaches and Modalities

A one-day scientific conference sponsored by the Inflammation Research Association

Date: October 13, 2017. 8:30 a.m. – 4:30 p.m.

Venue: Bell Harbor International Conference Center (2211 Alaskan Way, Pier 66
Seattle, WA 98121).

Confirmed speakers:

Mike Wittekind, CEO, Olympic Protein Technologies
John Babcook, Senior VP, Zymeworks, Inc.
Wei Yan, CEO, Sound Biologics
Chris Mehlin, Director, Peptide Drug Discovery, Fred Hutch
Fred Ramsdell, VP, Research, Parker Institute for Cancer Immunotherapy
Santanu Bose, Professor, Washington State University
Gabriela Hoyos, Leader of Immunobiology Group, Aptevo
Steven Ziegler, Director, Benaroya Research Institute
Lili Cheng, Senior Scientist I, Protagonist Therapeutics

All participants are welcome to submit posters.

For more information and to register – https://www.inflammationresearch.org/modulating-inflammation/

Questions? Email Dirk Smith at smith@thecddg.com

The Notices and Announcements section is provided as a service to the WSU community for sharing events such as lectures, trainings, and other highly transactional types of information related to the university experience. Information provided and opinions expressed may not reflect the understanding or opinion of WSU. Accuracy of the information presented is the responsibility of those who submitted it. The self-uploaded posts are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity.

WSU hosts 50th Murrow Symposium on April 6, featuring industry leaders and livestream access

April 3, 2026

Over three days, the symposium will feature keynote speakers, nationally recognized journalists, industry panels, and interactive student experiences.

By Brett Atwood, WSU Murrow College of Communication